Screener
PTC Therapeutics PTCT Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Income from operations | 44,959 | 970,225 |
| Interest expense, net | (49,030) | (34,092) |
| Other income (expense), net | 1,609 | (6,305) |
| (Loss) income before income tax expense | (2,462) | 929,828 |
| Income tax expense | (347) | (63,266) |
| Net (loss) income attributable to common stockholders | $(2,809) | $866,562 |
| Weighted-average shares outstanding: | ||
| Basic (in shares) | 82,521,023 | 78,115,836 |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's pre-tax income?
- PTC Therapeutics (PTCT) reported pre-tax income of -$2.46M in Q1 2026.
- How has PTC Therapeutics's pre-tax income changed year-over-year?
- PTC Therapeutics's pre-tax income decreased by 100.3% year-over-year, from $929.83M to -$2.46M.
- What is the long-term trend for PTC Therapeutics's pre-tax income?
- Over 3 years (2021 to 2024), PTC Therapeutics's pre-tax income has grown at a -11.2% compound annual growth rate (CAGR), from -$518.34M to -$363.12M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about PTC Therapeutics's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude